Newest member of the rapidly growing sulfanilamide family is a little number called N¹ dodecanoylsulfanilamide. It is a combination of the parent drug with part of a fat. Last week at the Baltimore meeting of the American Chemical Society Dr. Moses Leverock Crossley, director of Calco Chemical Co. at Bound Brook, N. J., announced that the new drug had successfully checked the growth of tuberculosis in guinea pigs.
Animals inoculated first with human tuberculosis germs and then with the new drug developed only mild infections at the site of the injections. All those inoculated with...
To continue reading:
or
Log-In
